Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients, Phase II

NCT00698399 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT00698399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00698399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients, Phase II
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
February 2, 2010
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant